• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The clinico-pathogenetic variants of cholestasis in different liver diseases].

作者信息

Ivashkin V T, Ivlev A S, Pliusnin S V, Vasil'ev A P

出版信息

Ter Arkh. 1992;64(2):6-9.

PMID:1509386
Abstract

To base the clinico-pathogenetic nonuniformity of cholestasis in different liver diseases, 135 patients distributed into groups were examined. Group I was made up of 48 patients with chronic persistent hepatitis, group II of 34 patients with chronic active hepatitis, group III of 29 patients with liver cirrhosis, and group IV of 24 patients with primary and metastatic liver carcinoma. The data obtained suggest the existence of different forms of cholestasis: multicomponent cholestasis, partial bilirubin cholestasis, partial choleacid cholestasis. In the group I patients, the incidence of cholestasis was 8.3%, in group II 2.9%, in group III 3.4%. The incidence of partial choleacid cholestasis was 4.2% in group I, 2.9% in group II, and 6.9% in group III. The presence of partial cholestasis may be caused by the impairment of the assumed "personal" carrier for different bile components.

摘要

相似文献

1
[The clinico-pathogenetic variants of cholestasis in different liver diseases].
Ter Arkh. 1992;64(2):6-9.
2
[The epidemiology of cholestasis in hepatopathies].
Ann Ital Med Int. 1993 Oct;8 Suppl:36S-40S.
3
Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.血清脂蛋白-X(LP-X)测定对慢性肝病胆汁淤积诊断的意义。
Pol Med Sci Hist Bull (1973). 1975 Sep-Dec;15(5-6):551-5.
4
[Plasma fibronectin in chronic liver diseases].
Recenti Prog Med. 1993 Sep;84(9):602-7.
5
Role of autoimmunity in nonviral chronic liver disease.自身免疫在非病毒性慢性肝病中的作用。
J Assoc Physicians India. 2000 Nov;48(11):1064-9.
6
High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.
J Hepatol. 2005 May;42(5):666-73. doi: 10.1016/j.jhep.2004.12.024.
7
[Alkaline leucocyte phosphatase (ALP) in acute and chronic liver diseases].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1973;99(2):170-9.
8
[Plasma fibronectin in chronic liver disease--marker of fibrosis?].
Przegl Lek. 1995;52(4):129-32.
9
[Cholestasis assessment by activity of antioxidant enzymes and composition of plasma lipoproteins in patients with liver diseases].[通过抗氧化酶活性和肝病患者血浆脂蛋白组成评估胆汁淤积]
Ter Arkh. 1998;70(4):40-2.
10
[Characteristics of chronic liver diseases with the presence of serum markers of the hepatitis B virus].伴有乙肝病毒血清标志物的慢性肝病的特征
Ter Arkh. 1988;60(11):23-8.